Hypertensive cardiac remodeling in males and females: from the bench to the bedside.

Cardiovascular diseases affect women and men differently: there are sex-dependent differences in the age at which they become manifest, in the pathophysiologic consequences of various insults, in the relative importance of risk factors, and in the responses to several treatments (as reviewed recently).1,2 Although many of these differences may relate to modifications of the lipid profile, as well as differences in the functions of endothelial and/or vascular smooth muscle cells, it is becoming clear that direct actions within the heart itself must also be considered. The current review will, therefore, focus on sex-specific differences in the remodeling responses of cardiac ventricles to various challenges. At baseline, male and female hearts display several differences: (1) coronary artery size is smaller in women3; (2) there are differences in the electrophysiological properties of the hearts, as females have faster resting heart rates and longer rate-corrected QT intervals4,5; (3) male and female hearts differ in terms of the pattern of expression of certain genes6; and (4) there are differences in the contractile properties of male and female hearts.7,8 More importantly, there are significant differences in the way male and female hearts respond to various challenges. In rodents, aortic banding-induced pressure overload increases left ventricular mass to the same extent in males and females, but function is better preserved in females, and males show an early transition to heart failure.9,10 In rats, volume overload induces eccentric dilated hypertrophy in male Sprague–Dawley rats but not in females.11 Differences in the remodeling responses can also be seen after myocardial infarction (MI), because female rats develop less thickening of noninfarcted regions and less pronounced diastolic dysfunction than their male counterparts,12 and post-MI rupture of the left ventricle is less frequent in female than in male mice.13,14 …

[1]  S. Neubauer,et al.  High-dose 17beta-estradiol treatment prevents development of heart failure post-myocardial infarction in the rat. , 2007, Basic research in cardiology.

[2]  H. Kiriazis,et al.  Sex dimorphism in cardiac pathophysiology: experimental findings, hormonal mechanisms, and molecular mechanisms. , 2006, Pharmacology & therapeutics.

[3]  W. Carver,et al.  17beta-estradiol modulation of angiotensin II-stimulated response in cardiac fibroblasts. , 2006, Journal of molecular and cellular cardiology.

[4]  P. Doevendans,et al.  Estrogen Receptor &bgr; Protects the Murine Heart Against Left Ventricular Hypertrophy , 2006 .

[5]  M. Barton,et al.  Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. , 2006, Hypertension.

[6]  Vera Regitz-Zagrosek,et al.  Therapeutic implications of the gender-specific aspects of cardiovascular disease , 2006, Nature Reviews Drug Discovery.

[7]  D. Federman,et al.  The biology of human sex differences. , 2006, The New England journal of medicine.

[8]  J. Gatewood,et al.  Roles of estrogen receptors α and β in differentiation of mouse sexual behavior , 2006, Neuroscience.

[9]  K. Lunetta,et al.  Estrogen Receptor (cid:1) Gene Variation Is Associated With Risk of Myocardial Infarction in More Than Seven Thousand Men From Five Cohorts , 2006 .

[10]  S. Davidge,et al.  Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha. , 2006, Cardiovascular research.

[11]  B. Llamas,et al.  A Genetic Locus Accentuates the Effect of Volume Overload on Adverse Left Ventricular Remodeling in Male and Female Rats , 2006, Hypertension.

[12]  L. Leinwand,et al.  Soy diet worsens heart disease in mice. , 2005, The Journal of clinical investigation.

[13]  K. Ley,et al.  Double jeopardy: how soluble P-selectin activates leukocytes in peripheral arterial occlusive disease. , 2005, Circulation research.

[14]  P. Doevendans,et al.  Estrogen receptor beta protects the murine heart against left ventricular hypertrophy. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[15]  J. Gatewood,et al.  Roles of estrogen receptors alpha and beta in differentiation of mouse sexual behavior. , 2006, Neuroscience.

[16]  S. Neubauer,et al.  High-dose 17β–estradiol treatment prevents development of heart failure post–myocardial infarction in the rat , 2006, Basic Research in Cardiology.

[17]  John W. Wilson,et al.  Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes? , 2005, Metabolism: clinical and experimental.

[18]  C. Schmid,et al.  Association of estrogen receptor beta gene polymorphisms with left ventricular mass and wall thickness in women. , 2005, American journal of hypertension.

[19]  B. Llamas,et al.  Distinct QTLs are linked to cardiac left ventricular mass in a sex-specific manner in a normotensive inbred rat intercross , 2005, Mammalian Genome.

[20]  J. S. Janicki,et al.  Effects of dietary phytoestrogens on cardiac remodeling secondary to chronic volume overload in female rats. , 2005, Journal of applied physiology.

[21]  J. S. Janicki,et al.  Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats. , 2005, Journal of cardiac failure.

[22]  E. Souzeau,et al.  Dietary isoflavones during pregnancy and lactation provide cardioprotection to offspring rats in adulthood. , 2005, American journal of physiology. Heart and circulatory physiology.

[23]  G. Baumann,et al.  Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. , 2005, European heart journal.

[24]  R. Karas,et al.  Molecular and Cellular Basis of Cardiovascular Gender Differences , 2005, Science.

[25]  A. Theocharis,et al.  Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors. , 2005, International journal of oncology.

[26]  K. Korach,et al.  Increased Mortality and Aggravation of Heart Failure in Estrogen Receptor-&bgr; Knockout Mice After Myocardial Infarction , 2005, Circulation.

[27]  J. S. Janicki,et al.  Modulation of cardiac mast cell-mediated extracellular matrix degradation by estrogen. , 2005, American journal of physiology. Heart and circulatory physiology.

[28]  James A. Clark,et al.  Estrogen receptor-β mediates male-female differences in the development of pressure overload hypertrophy , 2005 .

[29]  A. Dart,et al.  Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. , 2005, Cardiovascular research.

[30]  M. Hauer-Jensen,et al.  Cardiac function in hearts isolated from a rat model deficient in mast cells. , 2005, American journal of physiology. Heart and circulatory physiology.

[31]  P. Insel,et al.  Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Scheuer,et al.  Comparison of heart function in male and female rats , 1984, Basic Research in Cardiology.

[33]  R. H. Smith,et al.  Sex differences in myocardial contractility in the rat , 1983, Basic Research in Cardiology.

[34]  N. Kalinina,et al.  Transforming Growth Factor-β, Cell Signaling and Cardiovascular Disorders , 2005 .

[35]  J. Brouillette,et al.  Sex and strain differences in adult mouse cardiac repolarization: importance of androgens. , 2005, Cardiovascular research.

[36]  M. Berhow,et al.  Dietary isoflavones suppress endotoxin-induced inflammatory reaction in liver and intestine. , 2004, Cancer letters.

[37]  R. Karas,et al.  17&bgr;-Estradiol Reduces Cardiomyocyte Apoptosis In Vivo and In Vitro via Activation of Phospho-Inositide-3 Kinase/Akt Signaling , 2004, Circulation research.

[38]  Xiao-Jun Du Gender modulates cardiac phenotype development in genetically modified mice. , 2004, Cardiovascular research.

[39]  Yiwei Li,et al.  Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. , 2004, Neoplasia.

[40]  C. Deschepper,et al.  Characterization of blood pressure and morphological traits in cardiovascular-related organs in 13 different inbred mouse strains. , 2004, Journal of applied physiology.

[41]  K. Setchell,et al.  Not all soy products are created equal: caution needed in interpretation of research results. , 2004, The Journal of nutrition.

[42]  D. Grobbee,et al.  Estrogen, inflammation and cardiovascular risk in women: a critical appraisal , 2004, Trends in Endocrinology & Metabolism.

[43]  Yu-ming Wu,et al.  Effects of phytoestrogen genistein on myocardial ischemia/reperfusion injury and apoptosis in rabbits. , 2004, Acta pharmacologica Sinica.

[44]  K. Nakao,et al.  Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A. , 2004, Endocrinology.

[45]  A. Morgentaler,et al.  Risks of testosterone-replacement therapy and recommendations for monitoring. , 2004, The New England journal of medicine.

[46]  P. Doevendans,et al.  17&bgr;-Estradiol Antagonizes Cardiomyocyte Hypertrophy by Autocrine/Paracrine Stimulation of a Guanylyl Cyclase A Receptor-Cyclic Guanosine Monophosphate-Dependent Protein Kinase Pathway , 2004 .

[47]  P. Doevendans,et al.  17 (cid:1) -Estradiol Antagonizes Cardiomyocyte Hypertrophy by Autocrine/Paracrine Stimulation of a Guanylyl Cyclase A Receptor–Cyclic Guanosine Monophosphate–Dependent Protein Kinase Pathway , 2004 .

[48]  J. S. Janicki,et al.  Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy , 2004, Molecular and Cellular Biochemistry.

[49]  J. S. Janicki,et al.  The Dynamic Interaction Between Matrix Metalloproteinase Activity and Adverse Myocardial Remodeling , 2004, Heart Failure Reviews.

[50]  M. Mendelsohn,et al.  Hormonal regulation of normal vascular tone in males. , 2003, Circulation research.

[51]  R. London,et al.  Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol. , 2003, American journal of physiology. Heart and circulatory physiology.

[52]  P. Doevendans,et al.  17β‐Estradiol regulates the expression of endothelin receptor type B in the heart , 2003, British journal of pharmacology.

[53]  L. Leinwand,et al.  Sex is a potent modifier of the cardiovascular system. , 2003, The Journal of clinical investigation.

[54]  R. Iliescu,et al.  Androgen receptor independent cardiovascular action of the antiandrogen flutamide , 2003, Journal of Molecular Medicine.

[55]  R. Karas,et al.  17-beta-estradiol increases cardiac remodeling and mortality in mice with myocardial infarction. , 2003, Journal of the American College of Cardiology.

[56]  David Handelsman,et al.  Androgens and cardiovascular disease. , 2003, Endocrine reviews.

[57]  A. Murakami,et al.  Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-γ-induced IκB degradation in RAW264.7 macrophages , 2003 .

[58]  A. Dominiczak,et al.  Y is there a risk to being male? , 2003, Trends in Endocrinology & Metabolism.

[59]  S. Sankey,et al.  Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction. , 2003, American journal of physiology. Heart and circulatory physiology.

[60]  R. Iliescu,et al.  Abolition of End-Organ Damage by Antiandrogen Treatment in Female Hypertensive Transgenic Rats , 2003, Hypertension.

[61]  C. Klinge,et al.  Estrogenic activity in white and red wine extracts. , 2003, Journal of agricultural and food chemistry.

[62]  E. Lakatta,et al.  Sex- and age-dependent human transcriptome variability: Implications for chronic heart failure , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[63]  S. Davidge,et al.  Estrogen modulation of left ventricular remodeling in the aged heart. , 2003, Cardiovascular research.

[64]  Richard T. Lee,et al.  Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload. , 2003, Physiological genomics.

[65]  K. Channer,et al.  Heart failure as an inflammatory condition: potential role for androgens as immune modulators , 2002, European journal of heart failure.

[66]  Y. Giudicelli,et al.  Gender differences in hypothalamic tyrosine hydroxylase and alpha(2)-adrenoceptor subtype gene expression in cafeteria diet-induced hypertension and consequences of neonatal androgenization. , 2002, The Journal of pharmacology and experimental therapeutics.

[67]  J. S. Janicki,et al.  Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. , 2002, American journal of physiology. Heart and circulatory physiology.

[68]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[69]  P. Blackshear,et al.  Load-Dependent and -Independent Regulation of Proinflammatory Cytokine and Cytokine Receptor Gene Expression in the Adult Mammalian Heart , 2002, Circulation.

[70]  Yoh-Han Pao,et al.  Naturally occurring variation in cardiovascular traits among inbred mouse strains. , 2002, Genomics.

[71]  J. S. Janicki,et al.  Gender differences in cardiac remodeling secondary to chronic volume overload. , 2002, Journal of cardiac failure.

[72]  J. Rossouw,et al.  Hormones, genetic factors, and gender differences in cardiovascular disease. , 2002, Cardiovascular research.

[73]  M. Rosen,et al.  Effects of gonadal steroids on gender-related differences in transmural dispersion of L-type calcium current. , 2002, Cardiovascular research.

[74]  A. Matsumori,et al.  Evidence for a Role of Mast Cells in the Evolution to Congestive Heart Failure , 2002, The Journal of experimental medicine.

[75]  H. Wellens,et al.  17&bgr;-Estradiol Attenuates the Development of Pressure-Overload Hypertrophy , 2001, Circulation.

[76]  R. Hannan,et al.  Increased expression of UBF is a critical determinant for rRNA synthesis and hypertrophic growth of cardiac myocytes , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[77]  D. R. Gross,et al.  Effects of dietary phytoestrogen on global myocardial ischemia-reperfusion injury in isolated female rat hearts. , 2001, American journal of physiology. Heart and circulatory physiology.

[78]  C. Fiset,et al.  Gender-Based Differences in Cardiac Repolarization in Mouse Ventricle , 2001, Circulation research.

[79]  B. Katzenellenbogen,et al.  Activation of estrogen receptor β is a prerequisite for estrogen‐dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes , 2001, FEBS letters.

[80]  Mark A Sussman,et al.  Myocardial Akt Activation and Gender: Increased Nuclear Activity in Females Versus Males , 2001, Circulation research.

[81]  S. Barnes,et al.  Actions of the soy phytoestrogen genistein in models of human chronic disease: potential involvement of transforming growth factor beta. , 2001, Biochemical Society transactions.

[82]  J F Reckelhoff,et al.  Gender Differences in the Regulation of Blood Pressure , 2001, Hypertension.

[83]  C. Hayward,et al.  Effect of sex hormones on cardiac mass , 2001, The Lancet.

[84]  E. Lucchinetti,et al.  Anabolic‐androgenic steroids induce apoptotic cell death in adult rat ventricular myocytes , 2001, Journal of cellular physiology.

[85]  C. Deschepper,et al.  Functional Alterations of the Nppa Promoter Are Linked to Cardiac Ventricular Hypertrophy in WKY/WKHA Rat Crosses , 2001, Circulation research.

[86]  C. Curl,et al.  Effects of gender on intracellular [Ca2+] in rat cardiac myocytes , 2001, Pflügers Archiv.

[87]  J. S. Janicki,et al.  Contribution of ventricular remodeling to pathogenesis of heart failure in rats. , 2001, American journal of physiology. Heart and circulatory physiology.

[88]  C. Curl,et al.  Effects of gender on intracellular. , 2001, Pflugers Archiv : European journal of physiology.

[89]  D. Webb,et al.  Effects of Estrogen Replacement on Infarct Size, Cardiac Remodeling, and the Endothelin System After Myocardial Infarction in Ovariectomized Rats , 2000, Circulation.

[90]  E. Giardina Heart disease in women. , 2000, International journal of fertility and women's medicine.

[91]  E. Olson,et al.  Decoding calcium signals involved in cardiac growth and function , 2000, Nature Medicine.

[92]  C. Klinge,et al.  Resveratrol Acts as a Mixed Agonist / Antagonist for Estrogen Receptors a and b * , 2000 .

[93]  David J Harris,et al.  Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. , 2000, The New England journal of medicine.

[94]  M. Turner,et al.  Review of the Y chromosome and hypertension. , 2000, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[95]  B. Gersh,et al.  Sex differences in coronary artery size assessed by intravascular ultrasound. , 2000, American heart journal.

[96]  P. Anversa,et al.  Telomerase activity in rat cardiac myocytes is age and gender dependent. , 2000, Journal of molecular and cellular cardiology.

[97]  E. Sonnenblick,et al.  Cardiomyocyte aging is gender-dependent: the local IGF-1-IGF-1R system. , 2000, Heart disease.

[98]  A. Tchernitchin,et al.  Imprinting: Perinatal Exposures Cause the Development of Diseases During the Adult Age , 1999, Acta biologica Hungarica.

[99]  S. Neubauer,et al.  Evidence against a role of physiological concentrations of estrogen in post-myocardial infarction remodeling. , 1999, Journal of the American College of Cardiology.

[100]  M. G. Modena,et al.  Effects of transdermal 17beta-estradiol on left ventricular anatomy and performance in hypertensive women. , 1999, Hypertension.

[101]  C. F. Chen,et al.  Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. , 1999, Carcinogenesis.

[102]  P. Douglas,et al.  Gender Differences in Postinfarction Left Ventricular Remodeling , 1999, Cardiology.

[103]  C. Yan,et al.  Effects of genistein on invasion and matrix metalloproteinase activities of HT1080 human fibrosarcoma cells. , 1999, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[104]  M. Messina Legumes and soybeans: overview of their nutritional profiles and health effects. , 1999, The American journal of clinical nutrition.

[105]  P. Douglas,et al.  Gender differences in molecular remodeling in pressure overload hypertrophy. , 1999, Journal of the American College of Cardiology.

[106]  D. Newby,et al.  Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure. , 1999, Circulation.

[107]  M. Chappell,et al.  Estrogen regulation of angiotensin-converting enzyme mRNA. , 1999, Hypertension.

[108]  S. Barnes,et al.  Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. , 1998, The American journal of clinical nutrition.

[109]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[110]  P. Douglas,et al.  Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. , 1998, Journal of the American College of Cardiology.

[111]  J. Gwathmey,et al.  Androgen receptors mediate hypertrophy in cardiac myocytes. , 1998, Circulation.

[112]  S. Rosenkranz,et al.  Estrogen modulates AT1 receptor gene expression in vitro and in vivo. , 1998, Circulation.

[113]  E. Jackson,et al.  17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. , 1998, Hypertension.

[114]  R. Karas,et al.  Cardiac myocytes and fibroblasts contain functional estrogen receptors 1 , 1997, FEBS letters.

[115]  C. Thiemermann,et al.  Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase , 1997, British journal of pharmacology.

[116]  W. Catterall,et al.  Increased Expression of the Cardiac L-type Calcium Channel in Estrogen Receptor–deficient Mice , 1997, The Journal of general physiology.

[117]  K. Teisala,et al.  Impaired ovarian function and risk factors for atherosclerosis in premenopausal women. , 1996, Maturitas.

[118]  J. Seckl,et al.  Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. , 1996, Neuroendocrinology.

[119]  O. Hess,et al.  Sex-dependent differences in left ventricular function and structure in chronic pressure overload. , 1995, European heart journal.

[120]  P. Anversa,et al.  Gender differences and aging: effects on the human heart. , 1995, Journal of the American College of Cardiology.

[121]  G. Aurigemma,et al.  Gender differences in older patients with pressure-overload hypertrophy of the left ventricle. , 1995, Cardiology.

[122]  A. Grace,et al.  The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis , 1995, Nature Medicine.

[123]  A. Thorburn,et al.  The Tyrosine Kinase Inhibitor, Genistein, Prevents α-Adrenergic-Induced Cardiac Muscle Cell Hypertrophy by Inhibiting Activation of the Ras-MAP Kinase Signaling Pathway , 1994 .

[124]  R. Lauer,et al.  Factors affecting left ventricular mass in childhood: the Muscatine Study. , 1993, Pediatrics.

[125]  D. Levy,et al.  Sex differences in cardiac adaptation to isolated systolic hypertension. , 1993, The American journal of cardiology.

[126]  J. Le Pecq,et al.  Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. , 1990, Biochemical pharmacology.

[127]  S. Shroff,et al.  Myocardial collagen and mechanics after preventing hypertrophy in hypertensive rats. , 1989, American journal of hypertension.

[128]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[129]  A. Shoukas,et al.  Load Independence of the Instantaneous Pressure‐Volume Ratio of the Canine Left Ventricle and Effects of Epinephrine and Heart Rate on the Ratio , 1973, Circulation research.

[130]  Damodar Gujarati,et al.  Use of Dummy Variables in Testing for Equality between Sets of Coefficients in Linear Regressions: A Generalization , 1970 .